134 related articles for article (PubMed ID: 36318971)
1. Host Cell Transcriptional Tuning with CRISPR/dCas9 to Mitigate the Effects of Toxin Exposure.
Metzger D; Miller K; Lyon W; Migliozzi R; Pangburn HA; Saldanha R
ACS Synth Biol; 2022 Nov; 11(11):3657-3668. PubMed ID: 36318971
[TBL] [Abstract][Full Text] [Related]
2. Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner.
O'Geen H; Bates SL; Carter SS; Nisson KA; Halmai J; Fink KD; Rhie SK; Farnham PJ; Segal DJ
Epigenetics Chromatin; 2019 May; 12(1):26. PubMed ID: 31053162
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide determination of on-target and off-target characteristics for RNA-guided DNA methylation by dCas9 methyltransferases.
Lin L; Liu Y; Xu F; Huang J; Daugaard TF; Petersen TS; Hansen B; Ye L; Zhou Q; Fang F; Yang L; Li S; Fløe L; Jensen KT; Shrock E; Chen F; Yang H; Wang J; Liu X; Xu X; Bolund L; Nielsen AL; Luo Y
Gigascience; 2018 Mar; 7(3):1-19. PubMed ID: 29635374
[TBL] [Abstract][Full Text] [Related]
4. Anthrax Susceptibility: Human Genetic Polymorphisms Modulating ANTXR2 Expression.
Zhang Z; Zhang Y; Shi M; Ye B; Shen W; Li P; Xing L; Zhang X; Hou L; Xu J; Zhao Z; Chen W
Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26703731
[TBL] [Abstract][Full Text] [Related]
5. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing.
Moses C; Hodgetts SI; Nugent F; Ben-Ary G; Park KK; Blancafort P; Harvey AR
Sci Rep; 2020 Jul; 10(1):11393. PubMed ID: 32647121
[TBL] [Abstract][Full Text] [Related]
7. Investigating the Influence of
Archana CA; Sekar YS; Suresh KP; Subramaniam S; Sagar N; Rani S; Anandakumar J; Pandey RK; Barman NN; Patil SS
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674361
[No Abstract] [Full Text] [Related]
8. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors.
Piatek A; Ali Z; Baazim H; Li L; Abulfaraj A; Al-Shareef S; Aouida M; Mahfouz MM
Plant Biotechnol J; 2015 May; 13(4):578-89. PubMed ID: 25400128
[TBL] [Abstract][Full Text] [Related]
9. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
Goubert D; Koncz M; Kiss A; Rots MG
Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
[TBL] [Abstract][Full Text] [Related]
10. A review on CRISPR/Cas-based epigenetic regulation in plants.
Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
[TBL] [Abstract][Full Text] [Related]
11. A Cellular Stress Response Induced by the CRISPR-dCas9 Activation System Is Not Heritable Through Cell Divisions.
Johnston AD; Abdulrazak A; Sato H; Maqbool SB; Suzuki M; Greally JM; Simões-Pires CA
CRISPR J; 2020 Jun; 3(3):188-197. PubMed ID: 33560917
[TBL] [Abstract][Full Text] [Related]
12. A complex role of anthrax toxin receptor 2 polymorphisms and capillary morphogenesis protein 2 in ankylosing spondylitis pathogenesis.
Zhang Z; Yu K; Dai D; Yuan F; Liang F; Liu N; Xi Y; Sun YY
Clin Rheumatol; 2016 Sep; 35(9):2243-50. PubMed ID: 26728147
[TBL] [Abstract][Full Text] [Related]
13. Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis.
Reeves CV; Dufraine J; Young JA; Kitajewski J
Oncogene; 2010 Feb; 29(6):789-801. PubMed ID: 19901963
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of sgRNA target sites for CRISPR-mediated repression of TP53.
Lawhorn IE; Ferreira JP; Wang CL
PLoS One; 2014; 9(11):e113232. PubMed ID: 25398078
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-free targeted DNA demethylation using CRISPR-dCas9-based steric hindrance to identify DNA methylation marks causal to altered gene expression.
Sapozhnikov DM; Szyf M
Nat Protoc; 2022 Dec; 17(12):2840-2881. PubMed ID: 36207463
[TBL] [Abstract][Full Text] [Related]
16. Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.
Kabadi AM; Machlin L; Dalal N; Lee RE; McDowell I; Shah NN; Drowley L; Randell SH; Reddy TE
J Cyst Fibros; 2022 Jan; 21(1):164-171. PubMed ID: 34049825
[TBL] [Abstract][Full Text] [Related]
17. Synthetic CRISPR/dCas9-KRAB system driven by specific PSA promoter suppresses malignant biological behavior of prostate cancer cells through negative feedback inhibition of PSA expression.
Yang Y; Mei H; Han X; Zhang X; Cheng J; Zhang Z; Wang H; Xu H
Cell Mol Biol Lett; 2023 Nov; 28(1):96. PubMed ID: 38017385
[TBL] [Abstract][Full Text] [Related]
18. Bacillus anthracis lethal toxin represses MMTV promoter activity through transcription factors.
Kang Z; Webster Marketon JI; Johnson A; Sternberg EM
J Mol Biol; 2009 Jun; 389(3):595-605. PubMed ID: 19389405
[TBL] [Abstract][Full Text] [Related]
19. Short communication: An inducible CRISPR/dCas9 gene repression system in Lactococcus lactis.
Xiong ZQ; Wei YY; Kong LH; Song X; Yi HX; Ai LZ
J Dairy Sci; 2020 Jan; 103(1):161-165. PubMed ID: 31733872
[TBL] [Abstract][Full Text] [Related]
20. Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic Toolkit.
Song MK; Kim YS
Methods Mol Biol; 2024; 2761():81-91. PubMed ID: 38427231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
